Mastectomy plus reconstruction has higher complication rates and costs than lumpectomy plus radiation

Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B

Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer

Test to identity which breast cancer patients will respond to platinum-based chemotherapy

Overexpression of the enzyme APOBEC3B is linked to somatic mutagenesis in breast and other cancers

Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy

Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer

Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer

Addressing disparities in access to clinicians

ASH 2015: Highlights in mantle cell lymphoma

ASH 2015: Novel combination approaches for multiple myeloma

ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia